Healthcare / Drug Manufacturers - Specialty & GenericUpdated 2026-05-10 22:07 UTC

KRX/234080 stock hub

KRX/234080 has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

KRX/234080is not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

199.4B

Korea Stock Exchange

Market data

Live price

Current market quote for this ticker.

Current price

KRX/234080

In the news

Latest news · KRX/234080

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 9.8P50 17.1P75 31.9

Trailing P/E7

P25 12P50 23.1P75 39.5

ROE13.6

P25 -17.1P50 0.7P75 8.5

ROIC12

P25 -9P50 1.3P75 6.8

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All KRX/234080 market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

232

Groups with data

Currency

KRW

Showing 232 of 232 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	South Korea
Country code	KR
Employees	297
Enterprise value	KRW 239.5B
Exchange	Korea Stock Exchange
Financial currency	KRW
First seen	2026-05-10
Industry	Drug Manufacturers - Specialty & Generic
Isin	KR7234080000
Last refreshed	2026-05-10
Market cap	KRW 199.4B
Price	KRW 12,880
Price currency	KRW
Rev Per Employee	868,112,487x
Sector	Healthcare
Sic	2834
Symbol	krx/234080
Website	https://www.jw-lifescience.co.kr

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	14.34%
EV Earnings	8.37x
EV/EBIT	7.21x
EV/EBITDA	4.66x
EV/FCF	8.56x
EV/Sales	0.93x
FCF yield	14.03%
P/B ratio	0.9x
P/E ratio	6.97x
P/S ratio	0.77x
PE Ratio10 Y	15.19x
PE Ratio3 Y	6.58x
PE Ratio5 Y	12.56x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	12.89%
EBITDA Margin	19.95%
FCF margin	10.85%
Gross margin	28.02%
Gross Profit	KRW 72.3B
Gross Profit Growth	25.73%
Gross Profit Growth Q	23.42%
Gross Profit Growth3 Y	14.64%
Gross Profit Growth5 Y	4.04%
Net Income	KRW 28.6B
Net Income Growth	-34.97%
Net Income Growth Q	-74.63%
Net Income Growth Years	0%
Net Income Growth3 Y	24.12%
Net Income Growth5 Y	10.58%
Pretax Margin	12.31%
Profit Margin	11.09%
Profit Per Employee	KRW 96.3M
Profitable Years	15
ROA	6.46
Roa5y	7.42
ROCE	14.22
ROE	13.59
Roe5y	15.52
ROIC	12.02
Roic5y	12.22

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	16.47%
Cagr3y	6.69%
Cagr5y	-3.47%
Div CAGR3	3.23%
Div CAGR5	1.92%
EPS Growth	-34.99
EPS Growth Q	-74.68
EPS Growth Years	0
EPS Growth3 Y	24.12
EPS Growth5 Y	11.07
FCF Growth	-30.71%
FCF Growth Q	39.04%
FCF Growth3 Y	66.62%
FCF Growth5 Y	-1.92%
OCF Growth	-20.03%
OCF Growth Q	-10.36%
OCF Growth10 Y	4.58%
OCF Growth3 Y	42.1%
OCF Growth5 Y	-2.81%
Revenue Growth	15.89x
Revenue Growth Q	17.4x
Revenue Growth Quarters	16x
Revenue Growth Years	4x
Revenue Growth3 Y	10.92x
Revenue Growth5 Y	7.04x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	KRW 0.8
Assets	KRW 318.2B
Cash	KRW 10.5B
Current Assets	KRW 88.3B
Current Liabilities	KRW 84.4B
Debt	KRW 50.6B
Debt EBITDA	KRW 0.98
Debt Equity	KRW 0.23
Debt FCF	KRW 1.81
Equity	KRW 220.6B
Interest Coverage	11.72
Liabilities	KRW 97.6B
Long Term Assets	KRW 229.9B
Long Term Liabilities	KRW 13.2B
Net Cash	KRW -40.1B
Net Cash By Market Cap	KRW -20.1
Net Debt EBITDA	KRW 0.78
Net Debt Equity	KRW 0.18
Net Debt FCF	KRW 1.43
Tangible Book Value	KRW 143.7B
Tangible Book Value Per Share	KRW 9,273
WACC	5.79

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	1.05
Inventory Turnover	5.53
Net Working Capital	KRW 42.6B
Quick ratio	0.65
Working Capital	KRW 3.9B
Working Capital Turnover	KRW 17.57

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-0.03%
Dividend Growth	0%
Dividend Growth Years	0%
Dividend per share	KRW 500
Dividend Years	1
Dividend Yield	3.88%
Ex Div Date	2026-03-31
Last Dividend	KRW 550
Payout Frequency	Annual
Payout Ratio	27.07%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	16.45%
200-day SMA	12,951.8
3Y total return	21.45%
50-day SMA	12,916.6
50-day SMA vs 200-day SMA	50under200
5Y total return	-16.18%
All Time High	34,450
All Time High Change	-62.61%
All Time High Date	2018-04-11
All Time Low	10,000
All Time Low Change	28.8%
All Time Low Date	2025-02-05
ATR	240.1
Beta	0.31
Beta1y	0.01
Beta2y	0.08
Ch YTD	0.23
High	12,880
High52	15,580
High52 Date	2025-11-24
High52ch	-17.33%
Low	12,640
Low52	11,330
Low52 Date	2025-08-20
Low52ch	13.68%
Ma50ch	-0.28%
Price vs 200-day SMA	-0.55%
RSI	50.44
RSI Monthly	51.86
RSI Weekly	48.42
Sharpe ratio	0.65x
Sortino ratio	1.15
Total Return	3.85%
Tr YTD	4.58
Tr1m	3.62%
Tr1w	0.47%
Tr3m	4.91%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	KRW 33.2B
Operating Income Growth	-7.29
Operating Income Growth Q	-20.95
Operating Income Growth3 Y	7.06
Operating Income Growth5 Y	-3.37
Operating margin	12.89

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	8,563,266%
Net Borrowing	-18,558,485,950
Shares Insiders	0.11%
Shares Institutions	9.1%
Shares Out	15,484,554
Shares Qo Q	0.08%
Shares Yo Y	0.03%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	KRW 28B
Average Volume	33,032.05x
Bv Per Share	14,233.3
CAPEX	KRW -12.6B
Ch1m	3.62
Ch1w	0.47
Ch1y	11.61
Ch3m	0.55
Ch3y	7.07
Ch5y	-31.49
Ch6m	-1
Change	1.98%
Change From Open	1.82
Close	12,630
Days Gap	0.16
Depreciation Amortization	18,192,550,000
Dollar Volume	499,937,200
Earnings Date	2026-05-14
EBIT	KRW 33.2B
EBITDA	KRW 51.4B
EPS	KRW 1,847
F Score	6
FCF	KRW 28B
FCF EV Yield	11.68x
FCF Per Share	KRW 1,807
Financing CF	-26,300,762,950
Fiscal Year End	December
Founded	1,994
Goodwill	32,388,584,000
Graham Number	24320.79229
Graham Upside	88.83
Income Tax	KRW 3.1B
Investing CF	-13,368,604,330
Is Primary Listing	1
Last Earnings Date	2026-02-05
Last Report Date	2025-12-31
Last Split Date	2018-04-20
Last Split Type	Forward
Lynch Fair Value	KRW 19,544
Lynch Upside	51.74
Ma150	13,244.9
Ma150ch	-2.76%
Ma20	12,848
Ma20ch	0.25%
Net CF	867,394,230
Next Earnings Date	2026-05-14
Open	12,650
P FCF Ratio	7.13
P OCF Ratio	4.92
Payment Date	2026-04-24
Position In Range	100
Ppne	128,652,658,120
Price Date	2026-05-08
Price EBITDA	KRW 3.88
Ptbv Ratio	1.39
Relative Volume	1.18x
Revenue	257,829,408,640x
Tax By Revenue	1.22x
Tax Rate	9.89%
Tr6m	3.3%
Volume	38,815
Z Score	3

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

KRX/234080 dividend yield, growth & safety

Yield, payout sustainability, and the multi-year growth streak.

Dividend yield

+3.9%

$500 annual per share

Payout ratio

+27.1%

Share of earnings returned as dividends. Below 60% is generally sustainable.

5Y dividend CAGR

+1.9%

0 consecutive years of growth

Total shareholder yield

+3.9%

Next ex-dividend date: 2026-03-31

Performance

KRX/234080 stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns KRX/234080?

Insider, institutional, and short-interest positioning.

Institutional ownership

+9.1%

Share of float held by funds and institutions

Insider ownership

+0.1%

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

+0.0%

Negative means the company is buying back shares.

Technical

KRX/234080 momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

50.4

Neutral momentum band

Price vs 200-day MA

-0.6%

50/200-day relationship not available

Beta (5Y)

0.31

Less volatile than the market

Sharpe ratio

0.65

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About KRX/234080

Hub-level FAQ points readers to the deeper analysis pages.

What is the current krx/234080 stock rating?

krx/234080 is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full krx/234080 analysis?

The full report lives at /stocks/krx/234080/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for krx/234080?

The latest report frames krx/234080 around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the krx/234080 page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.